The cost‐utility of pitolisant as narcolepsy treatment

Kristian Bolin,Per‐Åke Niska,Laura Pirhonen,Pontus Wasling,Anne-Marie Landtblom

The cost‐utility of pitolisant as narcolepsy treatment

2020

Kristian Bolin
Per‐Åke Niska
Laura Pirhonen
Pontus Wasling
Anne-Marie Landtblom

Objectives The cost-effectiveness of available pharmacological treatments for narcolepsy is largely unknown. Available pharmacological treatments are associated with tolerability, abuse, and adhere ...

Keywords:

Pitolisant
Medicine
Narcolepsy
Pediatrics
Diabetes mellitus
Anesthesia
Tolerability
Intensive care medicine
Modafinil
adjunctive treatment
Cataplexy
Adverse effect
cost effectiveness
Standard treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations